New incident report
Incident Report Number: 2021-2659
Registrant Reference Number: 2020-CA-000201
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: CANADA
Prov / State: UNKNOWN
PMRA Registration No. 29930 PMRA Submission No. EPA Registration No.
Product Name: Hartz UltraGuard OneSpot Flea and Tick Cat Drops Spot-on
Yes
Unknown
Site: Animal / Usage sur un animal domestique
Animal's Owner
Cat / Chat
Maine Coon
1
Male
7
8.165
kg
Skin
Unknown / Inconnu
<=30 min / <=30 min
System
Unknown / Inconnu
No
No
Unknown/Inconnu
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 20-Jun-2020, a 7 year old, 8.165 kilogram, neutered, male, Maine Coon cat, in unknown condition, with no known concomitant medical conditions, was administered 1 tube of Hartz UltraGuard OneSpot Flea and Tick Cat Drops (S Methoprene) via the topical route by the animal owner. Approximately five minutes post application the cat developed application site itching, application site redness and application site hair loss. The clinical signs continued and the hair loss at the application site worsened post onset. On 21-Jun-2020, the cat developed drooling which resolved at an unspecified amount of time later. No treatments were performed and the cat had not been evaluated by a veterinarian. Bathing with liquid dish soap was recommended for product removal. The cat was previously administered the product for the first time, on approximately 20-Apr-2020. It was administered via the topical route by the animal owner. At an unspecified time post product administration on 20-Apr-2020, the cat developed a scab at the application site. On 27-Apr-2020, the clinical sign resolved without veterinary intervention. The animal owner reported both reactions during a single call. No further information was received.
Minor
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.